References
- Dawson A, Buckley N, Whyte I. What target pralidoxime concentration. J Toxicol Clin Toxicol 1997; 35: 227–228
- Medicis J J, Stock C M, Howland M A, Hoffman R S, Goldfrand LR. Pharmacokinetics following a loading plus a continuous infusion of pralidoxime compared with the traditional short infusion regimen in human volunteers. J Toxicol Clin Toxicol 1996; 34: 289–295
- Sundwall A. Minimum concentrations of nmethylpyridinium-2-aldoxime methane sulphonate (PS2) which reverse neuromuscular block. Biochem Pharmacol 1961; 8: 413–417
- Zvirblis P, Kondritzer AA. Prophylaxis against sarin poisoning in the rat by oral administration of pralidoxime chloride. J Pharmacol Exp Ther 1967; 157: 432–434
- Crook J W, Goodman A L, Colboum J L, Zvirblis P, Oberst F W, Wills JH. Adjunctive value of oral prophylaxis with the oximes 2-PAM lactate and 2-PAM methyl sulfonate to therapeutic administration of atropine in dogs poisoned by inhaled sarin vapor. J Pharmacol Exp Ther 1962; 136: 397–399